Full Course Description

The Lungs in Detail: From Health to Disease

Join Julia Rogers, DNP, APRN, CNS, FNP-BC, FAANP, in a course designed for healthcare professionals seeking to enhance their assessment skills and grasp fundamental pulmonary pathophysiology. Delve into topics such as lung disease causation, oxygen circulation, and medication necessity in a concise and easily understandable manner. Benefit from Julia's problem-based teaching style, featuring evolving case studies and interactive quizzes, to leave with a systematic approach to pulmonary assessment and a commitment to excellence in patient care.

Program Information


  • Differentiate lung diseases by distinguishing key identifying factors within the history and physical examination. 
  • Appropriately order and analyze the results of pulmonary function testing, ABGs, and radiologic testing for lung disorders. 
  • Integrate new evidenced-based guidelines to prescribe or manage medications for pulmonary conditions.
  • Utilize best practices based on the evidence for clinical strategies to evaluate, manage, and treat acute and chronic respiratory conditions.    
  • Evaluate the various pulmonary interventions in your toolbox to develop a collaborative and comprehensive plan of care.
  • Educate the patient and their families on occupational and environmental triggers and appropriate preventative measures.


The 3 P’s of Lung Disease 

  • Pathophysiology
  • Physical Assessment
  • Pharmacology and Plan of Care

Pulmonary Diagnostic Tests 

  • Pulmonary Function Test 
  • Acid Base and Electrolyte Disturbances
  • Radiologic Imaging

Pediatrics and Lung Disease

  • Asthma
  • Cystic Fibrosis
  • Acute Bronchitis

Triple Viral Threat 

  • Respiratory Syncytial Virus (RSV)
  • Influenza
  • SarsCoV-2 (COVID)

Common Lung Diseases

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Interstitial Lung Disease (ILD): Pulmonary Fibrosis 
  • Pneumonia: Community versus Hospital Acquired

Lung Emergencies

  • Pneumothorax
  • Acute Respiratory Failure 

Case Studies

  • Pediatrics: Asthma → Influenza → RSV
  • Adult: Long Covid → ILD
  • Geriatric: Older patient with COPD Presents to ED with exacerbation → Pneumonia Community Acquired → Respiratory distress → Pneumothorax → Respiratory Failure → End of Life Care

Target Audience

  • Nurses: 
    • Medical-surgical units
    • ED
    • Critical Care areas
    • Urgent Care Clinics
  • Respiratory therapists
  • Advanced practice providers.

Copyright : 12/15/2023

High Flow Nasal Cannula Use in Rapid Response Respiratory Distress Calls

High-flow nasal cannula gained popularity in acute care settings during the pandemic. High-flow nasal cannula oxygen therapy has been used in different patient care populations revealing strengths and weaknesses. Each strength and weakness will be discussed in this presentation. Find out if the research findings could lead you to consider this therapy, a new standard for rapid response calls on patients in respiratory distress.

Program Information


  1. Distinguish the difference between non-invasive ventilation and high-flow nasal cannula.
  2. Determine patient populations that benefit from high-flow nasal cannula oxygen therapy.
  3. Develop initiation and titration strategies for a patient on high-flow nasal cannula.
  4. Apply the ROX index when assessing a patient for high-flow nasal cannula therapy.


Media influence on respiratory support during COVID

  • Message that ventilators were killing covid patients
  • Praise for the “discovery” of high flow nasal cannulas (HFNC)
What is high flow nasal cannula
  • Settings
  • Comfort
  • Easy to use
  • Humidification
Does HFNC provide PEEP?
  • Therapeutic PEEP
  • Off set intrinsic PEEP
What patient populations benefit form HFNC
  • Hypoxic respiratory failure
  • Post extubation patients
  • CHF
  • AE COPD: Oxygen hemoglobin dissociation curve
Monitor a patient on HFNC
  • ROX index
  • Initiation
  • Provide medicated aerosol treatments with HFNC
Titrate and Discontinue HFNC

Clinical Outcomes
  • HOT-ER
  • Smaller trials/studies
Does the data support HFNC to be a routine for RRTs treating respiratory distressed patients?

Target Audience

  • Nurses 
  • Physicians 
  • Physician Assistants

Copyright : 11/10/2023

Managing COPD in Primary Care

COPD is a leading cause of morbidity and mortality in the United States and around the world. Unfortunately, many clinicians do not have the time or resources to optimally manage this complex disease. This presentation will provide an overview of COPD pathophysiology as well as best practices for managing the condition, including pharmacological, non-pharmacological, and advanced interventions. The presentation is designed to give busy clinicians immediately actionable recommendations to enhance patient care for the COPD community.

Program Information


  1. Determine potential cases of COPD and pre-COPD in their patient panels.
  2. Optimize medication management (including determining the best aerosol delivery device for each patient).
  3. Integrate more non-pharmacological interventions for patients including pulmonary rehabilitation and bronchoscopic lung volume reduction.


COPD Pathogenesis & Epidemiology

  • Screening tools
  • Phenotypes/etiotypes
  • Diagnostic options
Treatment Options
  • Pharmacological management
  • Tobacco cessation strategies
  • Pulmonary rehabilitation
  • Oxygen therapy
  • Surgical and bronchoscopic interventions
Additional Resources
  • GOLD
  • Peer support groups

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Physicians
  • Respiratory Therapists

Copyright : 05/12/2023

Stabilizing Respiratory Failure Using HFNC and NIPPV

An introduction to the causes and types of respiratory failure and the benefits and uses of two specific types of respiratory support modalities used in the hospital setting: High flow nasal cannula and non-invasive positive pressure ventilation.  

Program Information


  1. Differentiate the types of respiratory failure
  2. Evaluate the benefits of NIPPV and HFNC
  3. Determine clinical scenarios in which the use of NIPPV or HFNC may be beneficial 


  1. Definition of respiratory failure -Types: hypoxemic, hypercapnic, mixed, other 
  2. Respiratory support tool kit 
  3. High flow nasal cannula     - Settings     - Benefits     - When to use it 
  4. Non-invasive positive pressure ventilation     - Settings     - Benefits     - When to use it     - Contraindications 
  5. Comparison of HFNC and NIPPV 6. Clinical scenario discussions

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physicians
  • Physician Assistants

Copyright : 12/28/2022

Respiratory Pharmacology: Pharmacokinetics, Indications for Use and Patient Monitoring

Have you ever felt a lack of confidence when prescribing pulmonary medications?  You are not alone…   During this Summit session, Dr. Paul Langlois, APN, Ph.D., CCRN, CCNS, will take you through laboratory data, testing results and physical assessment findings to determine the appropriate respiratory diagnosis.  From there, you will take away the very latest updates to guide prescriptive decisions for the most common respiratory conditions you see in practice – asthma, COPD, COVID-19, TB, pulmonary hypertension, & pneumonia.  This jam-packed presentation is sure to leave you with new insights and evidence guidelines to support patients optimally.   

Program Information


  1. Determine the best medications to use during acute asthma attack. 
  2. Manage the current recommended medications for the COVID-19 patient both out- and in-patient. 
  3. Formulate a medication regimen for a tuberculosis patient, both newly diagnosed and with drug-resistant tuberculosis. 
  4. Devise the treatment protocol for a patient with pulmonary hypertension. 
  5. Plan for optimal antibiotic selection for the patient with bacterial pneumonia. 


Asthma – Not Just Bronchodilators Anymore 

  • How is asthma diagnosed? 
  • Global Initiative for Asthma (GINA) medication options 
  • Role of corticosteroids in asthma treatment 
  • Short acting beta agonists (SABA), long-acting beta agonists (LABA) - the difference and monitoring parameters 
  • Muscarinic antagonists, leukotriene modifiers and phosphodiesterase inhibitors - must know indications and contraindications  
  • Monoclonal antibodies for asthma relief 

Chronic Obstructive Pulmonary Disease (COPD) – Long Term Pharmacologic Therapies 

  • COPD causes, symptoms and diagnostic tests 
  • Non-pharmacologic treatments 
  • SABA and LABA - when and how much 
  • Inhaled corticosteroids alone or in combination with bronchodilators 
  • Vaccines are a must – which ones and at what age to administer 


  • Laboratory parameters for SARS-CoV2 
  • How effective are all those COVID-19 vaccines 
  • Which antiviral medications are FDA approved and which are still in clinical trials? 
  • Dexamethasone is effective - but only in certain patient populations 

Tuberculosis (TB): Still Prevalent and Highly Contagious 

  • What is Mycobacterium tuberculosis and how is it detected? 
  • First line medications for drug susceptible TB (doses, how often & how long to take) 
  • Multi-drug resistant TB treatments 

Pulmonary Hypertension 

  • Diagnosis of pulmonary hypertension  
  • 12-lead ECG results in a patient with pulmonary hypertension 
  • Select between calcium channel blockers, phosphodiesterase inhibitors, endothelin receptor antagonizes and prostacyclin agonists 


  • Community acquired treatment options 
  • Antibiotic options based on patient history 
  • Hospital acquired pharmacology 
  • How to treat methicillin resistant staphylococcus aureus

Target Audience

  • Nurses
  • Nurse Practitioners
  • Pharmacists
  • Physicians
  • Physician Assistants
  • Respiratory Therapists

Copyright : 05/19/2022

Asthma Management and Medication Devices

Asthma management is an ever-evolving field with new medications, guidelines, and strategies...making it hard to find the information you need. Look no further! This course is designed to empower clinicians like you with the latest knowledge and skills needed to stay ahead of the curve and prescribe confidently by exploring the current recommendations and latest advancements in asthma treatment, including precision medicine. 

Program Information


  1. Determine the medications used in the treatment of asthma, their mechanism of action, and adverse effects
  2. Describe different inhaler techniques used by patients with asthma.
  3. Recognize the most appropriate device for delivery of asthma medication based on patient’s condition. .
  4. Discuss emerging therapies for asthma, specifically the role of biologic agents, including guideline recommendations and supporting clinical evidence.


Asthma Management and Medication Devices 

  • Classification
  • Stepwise approach
  • Short-acting beta agonists (SABA)
  • Inhaled Corticosteroids (ICS)
  • Biologics
  • Single Maintenance and Reliever Therapy (SMART)
  • Global Initiative for Asthma (GINA)
  • National Asthma Education and Prevention Program Coordinating Committee (NAEPPCC) Expert Panel 4 (EPR-4)

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Asthma Educators
  • Respiratory Therapists
  • Other Clinicians Who Care For Patients With Asthma

Copyright : 09/27/2023

Pediatric Respiratory Conditions: Challenges in Managing Upper versus Lower Airways

Children are not small adults, and infants are not small children. Each are unique and require different interventions and treatment modalities. In today’s managed care and “decreased length of stay” environment, it is imperative that nurses and other healthcare providers in all health care settings-from home to primary care to acute care-be prepared to identify and intervene with respiratory situations as early as possible.

Secondary to both anatomical and physiological etiologies, children with respiratory conditions may present with acute illnesses, flare-ups of chronic conditions or life-threatening complications. As an example: the latest statistics indicate that about 1 in 10 children in the United States have a diagnosis of asthma. Rapid assessment and immediate intervention is oftentimes vital; yet long term chronic mismanagement can lead to significant issues. You will learn practical strategies to integrate symptomology and appropriate diagnostics into your differential diagnosis; enhance your ability to pinpoint etiology by understanding the inter-relationship of respiratory signs and symptoms; and to differentiate when to treat “cause” versus “symptom.”

This seminar will provide you with the knowledge you need to manage numerous respiratory conditions that are the cause for children seeking health care, and oftentimes hospitalization. You will receive the latest information on:

  • Traditional, improved and new medications and devices
  • Urgent and emergent management and interventions
  • Distinguishing between the “linked” airway disorders that determine upper versus lower airway etiology and manifestations

Your speaker Stephen Jones will discuss some of the pharmacological and non-pharmacological treatments for upper and lower respiratory conditions. He will help you identify the role of appropriate oxygen therapy in numerous situations, and to understand PFT’s and various technologies that are utilized when managing children with pulmonary issues. Discover what the pulse oximeter really signifies! Stephen’s long-standing passion for optimal pediatric care will be evident throughout this presentation.

His vast experiences and clinical management of these children will be shared, in a professional, educational yet fun learning experience. He is excited to share his wealth of knowledge, and help spread the “evidence based” word! In this endeavor, Stephen will provide the skills and knowledge for you to improve the outcomes of these children, and minimize negative sequalae. We know that you will find him positive, upbeat, energetic, full of evidence based information, practical, motivating, humorous, and willing to go the extra mile to make this program as success!

TOP 5 PROBLEMS this program will seek to solve:

  1. Gain an understanding of the manifestations of upper and lower respiratory conditions.
  2. Learn the evidence behind the recommended management guidelines.
  3. Describe and examine the step management for asthma.
  4. Identify appropriate non-pharmacological and pharmacological interventions for respiratory conditions
  5. Prevent misuse of non-evidence-based interventions

Program Information


  1. Discuss the importance of the physical exam, history and basic diagnostic tests.
  2. Assess and evaluate the underlying causes and triggers for common upper and lower respiratory conditions.
  3. Differentiate between signs and symptoms, as opposed to the “cause”, for upper and lower respiratory conditions.
  4. Discuss the appropriate utilization of various technologies used with respiratory conditions and their clinical significance.
  5. Recommend appropriate interventions for the child manifesting either an upper or lower respiratory condition.


History taking and physical assessment

  • Developmentally and age appropriate techniques
  • Determining cause versus symptom and the ‘inflammatory response”
  • Differentiating Upper versus Lower respiratory conditions
  • ”5 Fingered assessment”
Non-pharmacological: airway/ENT medications, airway clearance, pulse oximeter
  • Oxygen therapy: devises, flow rates
  • mist/humidification
  • Asthma meds and devised used (MDI/spacer, DPI, nebulizer)
  • Chest physiotherapy; concepts and products
Pharmacological Choices: OTC versus prescription
  • Antimicrobials (anti-bacterial, anti-viral, anti-fungal)
  • Reactive airways: rescue versus controller medications
  • ”cold and cough” medications
Laboratory Values
  • Significance of numbers
  • CBC, RAST testing, Immunoglobins
Underlying triggers
  • Environmental
  • Infectious
  • Anatomical
  • Hygiene hypothesis
Apnea: central and obstructive

Upper respiratory conditions
  • Pathophysiology of airways
  • Infectious ENT related: sinusitis, tonsillitis
  • Croup and laryngomalacia
  • Evidence based management
Lower respiratory conditions
  • Pathophysiology of airways
  • Infectious: bronchiolitis/RSV and HMV; pneumonia
  • Anatomical: asthma
  • Evidence based management, “step management” for asthma

Target Audience

  • Nurses
  • NPs
  • APRNs
  • Physician Assistants
  • Physicians
  • Respiratory Therapists

Copyright : 07/13/2023